PAYX
57
-2
WMB
68
-2
VLO
42
2
NRG
50
-2
NOC
40
-10
MMM
42
5
OXY
55
6
HPE
70
2
NWS
79
-4
MA
67
-5
WHR
70
4
MU
32
-6
LOW
58
2
NKE
33
2
NI
73
3
LB
63
-4
TROW
51
-2
SJM
16
-3
PDCO
30
-6
SIG
47
-2
PAYX
57
-2
WMB
68
-2
VLO
42
2
NRG
50
-2
NOC
40
-10
MMM
42
5
OXY
55
6
HPE
70
2
NWS
79
-4
MA
67
-5
WHR
70
4
MU
32
-6
LOW
58
2
NKE
33
2
NI
73
3
LB
63
-4
TROW
51
-2
SJM
16
-3
PDCO
30
-6
SIG
47
-2
Financhill
Back

Range Cancer Therapeutics ETF Vs. Neurogene Industry Stock Comparison

Sell
44

CNCR
Range Cancer Therapeutics ETF

Last Price:
15.24
Seasonality Move:
1.85%
Sell
5

NGNE
Neurogene

Last Price:
39.61
Seasonality Move:
50.43%
Sell
44
Range Cancer Therapeutics ETF (CNCR) is a Sell

Is Range Cancer Therapeutics ETF a Buy, Sell or Hold?

  • The current Range Cancer Therapeutics ETF [CNCR] share price is $14.80. The Score for CNCR is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • CNCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
5
Neurogene (NGNE) is a Sell

Is Neurogene a Buy, Sell or Hold?

  • The current Neurogene [NGNE] share price is $39.54. The Score for NGNE is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
  • NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

CNCR Stock Price Chart

What is Range Cancer Therapeutics ETF's stock price today?

  • The Range Cancer Therapeutics ETF share price today is $14.80
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CNCR is experiencing selling pressure, which indicates risk of future bearish movement.

NGNE Stock Price Chart

What is Neurogene's stock price today?

  • The Neurogene share price today is $39.54
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NGNE is experiencing selling pressure, which indicates risk of future bearish movement.

CNCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.09 Buy
Relative Strength Index (14 RSI): 45.09 Sell
Chaikin Money Flow: -2025 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.73 - 15.45) Sell
Bollinger Bands (100): (14.08 - 15.46) Buy

NGNE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.3 Buy
Relative Strength Index (14 RSI): 39.1 Sell
Chaikin Money Flow: -346626 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.29 - 61.53) Sell
Bollinger Bands (100): (34.11 - 50.51) Sell

CNCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.36 Sell
20-day SMA: 15.14 Sell
50-day SMA: 15.08 Sell
200-day SMA: 15.09 Sell
8-day EMA: 15.24 Sell
20-day EMA: 15.16 Sell
50-day EMA: 15.03 Sell
200-day EMA: 14.63 Buy

NGNE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 60.39 Sell
20-day SMA: 53.17 Sell
50-day SMA: 46.66 Sell
200-day SMA: 38.93 Buy
8-day EMA: 54.03 Sell
20-day EMA: 53.18 Sell
50-day EMA: 48.36 Sell
200-day EMA: 38.47 Buy

Range Cancer Therapeutics ETF Earnings Growth & CNCR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Neurogene Earnings Growth & NGNE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.

Range Cancer Therapeutics ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Neurogene Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):